scispace - formally typeset
J

Jan Wålinder

Researcher at Linköping University

Publications -  47
Citations -  2488

Jan Wålinder is an academic researcher from Linköping University. The author has contributed to research in topics: Citalopram & Paroxetine. The author has an hindex of 26, co-authored 47 publications receiving 2431 citations. Previous affiliations of Jan Wålinder include University of Nevada, Reno.

Papers
More filters
Journal ArticleDOI

Long-term effects of an educational program for general practitioners given by the Swedish Committee for the Prevention and Treatment of Depression.

TL;DR: The results indicate that educational programs that can have pronounced effects on the health care system have to be repeated approximately every 2 years if long‐term effects are to be expected.
Journal ArticleDOI

Frequency of suicide on Gotland after systematic postgraduate education of general practitioners.

TL;DR: Programs aiming at giving GPs increased capacity and responsibility to treat patients with affective disorders do not increase the frequency of suicide and better primary treatment of patients with depressive disorders may reduce the suicide rate in a given area.
Journal ArticleDOI

Prevalence, Incidence and Sex Ratio of Transsexualism

TL;DR: The prevalence, incidence and sex ratio of transsexualism in Sweden is low but the sex ratio is high and the number of women diagnosed with the disease is high.
Journal ArticleDOI

Factors predictive of regret in sex reassignment

TL;DR: The results of logistic regression analysis indicated that two factors predicted regret of sex reassignment, namely lack of support from the patient's family, and the patient belonging to the non‐core group of transsexuals.
Journal ArticleDOI

Therapeutic drug monitoring of selective serotonin reuptake inhibitors influences clinical dosing strategies and reduces drug costs in depressed elderly patients.

TL;DR: The effects of a therapeutic drug monitoring routine of selective serotonin reuptake inhibitors (SSRIs) on treatment strategies and drug costs in depressed elderly patients are described and evaluated.